[en] BACKGROUND: Recent reports indicated negative effects of hydroxyethylstarch (HES) on renal function. The goal of this large scale retrospective study was to detect whether there was an association between postoperative deterioration of renal function and the use of HES 200 kD, 0.5 DS in the cardiac surgery setting. METHODS: Retrospective analysis of daily collected data in 3124 patients who underwent coronary artery bypass and/or valvular surgery. Three groups were compared according to differences in fluid therapy: --GEL: gelatin was used as priming fluid of extracorporeal circulation (ECC) and for postoperative filling (n = 1276). --MIX: HES was used as priming fluid of ECC an gelatin was used for postoperative filling (n = 1008). --HES: HES was used as priming fluid of ECC and for postoperative filling (n = 840). MAIN RESULTS: There were no significant differences in postoperative serum creatinine concentrations between the 3 groups: GEL: 12,2 +/- 0,5 mg/l; MIX: 12,3 +/- 0.5 mg/l; HES: 12,3 +/- 0.6 mg/l. The need for postoperative extrarenal epuration was not significantly different between the 3 periods: GEL: 2,9%; MIX: 3,1%; HES: 3,8%. CONCLUSION: The use of HES 200 kD, 0.5 DS in cardiac surgery does not seem to be associated with a clinically significant deterioration of postoperative renal function.
Disciplines :
Anesthesia & intensive care
Author, co-author :
Wiesen, Patricia ; Centre Hospitalier Universitaire de Liège - CHU > Soins intensifs
Hinder F., Poelaert J. I., Schmidt C., et al., Assessment of cardiovascular volume status by transoesophageal echocardiography and dye dilution during cardiac surgery, EUR. J. ANAESTHESIOL., 15, 633-640, 1998.
Tschaikowsky K., Neddermeyer U., Pscheidl E., et al., Changes in circulating blood volume after cardiac surgery measured by a novel method using hydroxyethyl starch, CRIT. CARE MED., 28 (2), 336-341, 2000.
Ekery D. L., Davidoff R., Orlandi Q. G., et al., Imaging and diagnostic testing: diastolic dysfunction after coronary artery bypass grafting: a frequent finding of clinical significance not influenced by intravenous calcium, AM. HEART J., 145 (5), 896-902, 2003.
Warren B. B., Durieux E M., Hydroxyethyl Starch: Safe or Not?, ANESTH. ANALG., 84, 206-212, 1997.
Ragaller J. R. M., Theilen H., Koch T., Volume Replacement in Critically Ill Patients with Acute Renal Failure, J. AM. Soc. NEPHROL., 12, S33-S39, 2001.
Boldt J., Hydroxyethylstarch as a Risk Factor for Acute Renal Failure: Is a Change of Clinical Practice Indicated?, DRUG SAFETY, 25 (12), 837-846, 2002.
Cittanova M. L., Leblanc I., Legendre C. H., et al. Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients, LANCET, 348, 1620-1622, 1996.
Schortgen F., Lacherade J. C., Bruneel F., et al., Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study, LANCET, 357, 911-916, 2001.
Deman A., Peeters P., Sennesael J., Hydroxyethyl starch does not impair immediate renal function in kidney transplant recipients: a retrospective, multicentre analysis, NEPHROL. DIAL. TRANSPLANT, 14, 1517-1520, 1999.
Chertow M. G., Levy M. E., Hammermeister E. K., et al., Independent Association between Acute Renal Failure and Mortality following Cardiac Surgery, AM. J. MED., 104, 343-348, 1998.
Chertow M. G., Lazarus M. J., Christiansen L. C., et al., Preoperative Renal Risk Stratification, CIRCULATION, 95 (4), 878-884, 1997.
Suen W. S., Mok C. K.,Chiu S. W., et al., Risk factors for development of acute renal failure (ARF) requiring dialysis in patients undergoing cardiac surgery, ANGIOLOGY, 49, 789-800, 1998.
Corwin H. L., Sprague S. M., Delaria G. A., et al., Acute renal failure associated with cardiac operations, J. THORAC. CARDIOVASC. SURG., 98, 1101-1112, 1989.
Baron J. F., Pharmacologie des hydroxyéthylamidons de bas poids moléculaire, ANN. FR. ANESTH. RÉANIM., 11, 509-515, 1992.
Allison K. P., Gosling P., Jones S., et al., Randomized trial of hydroxyethyl starch versus gelatine for trauma resuscitation, J. TRAUMA, 47 (6), 1114-1121, 1999.
Boldt J., Brenner T., Lehmann A., et al., Influence of two different volume replacement regimens on renal function in elderly patients undergoing cardiac surgery: comparison of a new starch preparation with gelatin, INTENSIVE CARE MED., 29 (5), 763-769, 2003.
Altman C., Bernard B., Vitte R. L., et al., Randomized comparative multicenter study of hydroxyethyl starch versus albumin as a plasma expander in cirrhotic patients with tense ascites treated with paracentesis, EUR. J. GASTROENTEROL. HEPATOL., 10 (1), 5-10, 1998.
Jungheinrich C., Scharpf R., Wargenau M., et al., The Parmacokinetics and Tolerability of a Intravenous Infusion of the New Hydroxyethyl Starch 130/0.4 (6%, 500 ml) in Mild-to-Severe Renal Impairment, ANAESTH. ANALG., 95, 544-551, 2002.